Is CRP Elevated in Shingles?
Yes, C-reactive protein (CRP) is typically elevated in patients with herpes zoster (shingles), though the elevation is often modest and not universally present.
Evidence from Research Studies
Multiple recent studies consistently demonstrate CRP elevation in shingles patients compared to healthy controls:
A 2022 study found significantly increased CRP levels in herpes zoster patients compared to healthy controls (p < 0.001) 1. The elevation correlated with disease severity and was particularly pronounced in patients who developed postherpetic neuralgia (PHN).
A 2020 study similarly confirmed elevated high-sensitivity CRP (hsCRP) levels in HZ patients versus controls (P < 0.001), with levels associated with both rash and pain severity 2.
A 2024 meta-analysis of 13 studies involving 1,373 participants definitively established that CRP levels are significantly higher in the HZ group compared to controls 3. This represents the strongest evidence available, synthesizing multiple studies to confirm the association.
A 2018 prospective study identified elevated CRP as a significant predictor of PHN development, though erythrocyte sedimentation rate (ESR) showed stronger correlations 4.
Clinical Context and Limitations
However, CRP elevation in shingles has important caveats:
General signs of infection, including fever and elevated CRP, were found in only approximately half of patients with VZV neurological manifestations 5. This indicates CRP is not a sensitive marker for all presentations of herpes zoster.
CRP is a nonspecific acute-phase reactant that rises 4-6 hours after inflammatory insult and peaks at 36-50 hours 6. It cannot differentiate between bacterial infections and non-infectious inflammatory causes, limiting its diagnostic specificity for shingles specifically.
The magnitude of CRP elevation in shingles is generally modest compared to bacterial infections. While bacterial infections typically show median CRP values of 120 mg/L, viral infections show lower elevations around 32 mg/L 7.
Clinical Utility
CRP measurement in shingles is most useful for:
- Predicting risk of postherpetic neuralgia: Higher baseline CRP levels correlate with increased PHN risk 1, 4
- Assessing disease severity: CRP levels track with clinical severity of HZ 1
- Identifying patients needing closer monitoring: Elevated CRP combined with other inflammatory markers (ESR, lymphocyte count) identifies high-risk patients 4
CRP is NOT useful for:
- Diagnosing shingles itself (clinical diagnosis based on dermatomal vesicular rash remains primary)
- Distinguishing shingles from bacterial superinfection (lacks specificity)
- Ruling out shingles when normal (approximately 50% of patients may have normal CRP) 5
Practical Recommendations
In clinical practice, do not rely on CRP alone for shingles diagnosis or management. The diagnosis remains clinical, based on characteristic unilateral dermatomal vesicular eruption with pain 8, 9. Consider measuring CRP at baseline in patients with:
- Severe or disseminated disease
- Risk factors for PHN (age >60, severe acute pain, extensive rash)
- Suspected complications requiring hospitalization
- Immunocompromised status
Elevated CRP (particularly >10 mg/L) in a shingles patient should prompt consideration of:
- More aggressive antiviral therapy
- Enhanced pain management strategies
- Closer follow-up for PHN prevention
- Evaluation for bacterial superinfection if clinically indicated